Grace Therapeutics, Inc. Shares Issued
Grace Therapeutics, Inc. (GRCE) had Shares Issued of 16.27 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-13
- 2026-06-30: Common Stock, Shares, Issued 16.27M shares.
- 2026-03-31: Common Stock, Shares, Issued 16.02M shares.
- 2025-12-31: Common Stock, Shares, Issued 15.47M shares.
- 2025-09-30: Common Stock, Shares, Issued 14.13M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 16.27M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 16.02M shares 10-Q · filed 2026-08-13 | |
| 2025-12-31 | 15.47M shares 10-Q · filed 2026-02-12 | |
| 2025-09-30 | 14.13M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 13.83M shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 13.72M shares 10-K · filed 2026-06-18 | |
| 2024-12-31 | 10.14M shares 10-Q · filed 2025-02-13 | |
| 2024-03-31 | 9.40M shares 10-K · filed 2025-06-23 | |
| 2023-09-24 | 1.95M shares 10-Q · filed 2024-08-09 | |
| 2023-06-30 | 7.44M shares 10-Q · filed 2023-08-11 | |
| 2023-03-31 | 7.44M shares 10-K · filed 2024-06-21 | 44.61M shares 10-K · filed 2023-06-23 |
| 2022-03-31 | 44.29M shares 10-K · filed 2023-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |